Policybazaar is growing fast. But can PB Health change the story?

When most of us think about buying insurance, Policybazaar is probably one of the first names that comes to mind.

Over the years, PB Fintech has built one of India's largest online insurance marketplaces. Customers compare policies, buy them through the platform, and PB Fintech earns a commission from insurers.

But the company is no longer just an insurance comparison platform.

It now has Policybazaar, Paisabazaar, PB Partners and PB Health under its umbrella. And the latest numbers suggest that this transformation is starting to show up in its financials.

So, is PB Fintech simply becoming a bigger insurance distributor? Or is it building a much larger financial services ecosystem?

Let's break it down.

From comparing policies to selling financial products:

PB Fintech has two main businesses.

The first is Policybazaar, its insurance marketplace and broking business. The second is Paisabazaar, a marketplace for credit cards, personal loans, and other credit products.

It also has newer businesses such as PB Partners, which helps insurance agents sell policies, its UAE insurance business, and Policybazaar for Business, which focuses on corporate insurance.

The business model is simple.

PB Fintech brings customers to insurers and lenders, helps complete the transaction, and earns a commission.

And the opportunity is large.

India remains an underpenetrated insurance market, while the number of insurers has increased significantly from the days when LIC dominated the industry.

And it is slowly taking more share:

PB Fintech's share of the overall insurance premium market increased from around 1.4% in FY21 to roughly 4% in FY26.

The company is doing even better in health insurance.

Its health insurance market share is around 20%, while its health business is growing at roughly 68%, compared with around 20% for the industry.

New premium growth, excluding savings products, has also remained around 39–40%.

The company is therefore not just riding the insurance market's growth. It is gaining share as well.

The more interesting part is what happens after the sale:

Selling an insurance policy is only the beginning.

Every year, customers have to renew their policies. This creates recurring revenue for PB Fintech.

The company already generates around ₹900 Cr of renewal income, which is a high-margin business because the cost of acquiring the customer again is much lower.

And because most policyholders don't claim every year, a customer can potentially generate revenue for several years.

This recurring income can become increasingly valuable as the customer base grows.

There is still a gap in PB Partners:

PB Partners has around 5 lakh registered agents, but only about 1.13 lakh are active.

That's a significant gap.

The opportunity is to make more of these partners active and increase the business generated by each one. If PB Fintech can do that, it can grow its distribution without relying entirely on direct customer acquisition.

But the segment faces competition from players such as Turtlemint, while Paisabazaar competes with BankBazaar.

The financial transformation is hard to ignore:

The biggest change in PB Fintech has been its move towards profitability.

Between Q1 FY22 and Q1 FY27, quarterly revenue increased from ₹238 Cr to ₹1,888 Cr, a CAGR of roughly 51%.

At the same time, PAT margin improved from around -47% to 9%.

Q1 FY27 continued this trend:

• Operating revenue grew 40% YoY to ₹1,888 Cr

• Group insurance premium increased 41% to ₹8,372 Cr

• Core insurance revenue grew 46%

• Core credit revenue grew 25%

• PAT jumped 92% YoY to ₹163 Cr

Management also said trailing 12-month PAT would be around ₹750 Cr, plus or minus, while its FY27 target is around ₹1,000 Cr.

So PB Fintech is slowly moving from a growth-at-any-cost story to a growth-plus-profitability story.

Then comes PB Health:

This is probably the most interesting part of the story.

Through PB Health, PB Fintech is expanding into hospitals, pharmacies, and diagnostics.

The logic is straightforward.

Today, Policybazaar helps customers buy health insurance. If PB Health also participates in the healthcare delivery process, it could have greater control over the treatment and claims experience.

It could also increase the lifetime value of each customer.

But there is a catch.

Running hospitals is very different from running an online marketplace. It requires capital, infrastructure, doctors, and operational expertise.

PB Fintech owns only 28% of PB Health, with the majority stake held by US-based PE firm General Catalyst.

So this is both an opportunity and a risk.

In Q1 FY27, PB Health reported a loss of around ₹7 Cr. The company received approval to start billing at its second hospital, while management said monthly revenue at Fitterfly has increased four times since its acquisition.

Management's internal target is for PB Health to reach around ₹500 Cr annual revenue run-rate and break-even by March 2027.

That's ambitious, and execution will be key.

Regulation remains a risk:

A GST-related change removing input tax credit for insurers could put pressure on commissions paid to brokers.

Management estimates that if take-rates fall by around 2%, the potential impact on PAT guidance could be ₹250–300 Cr.

That's meaningful when the company is targeting roughly ₹1,000 Cr PAT.

So investors need to watch not just premium and revenue growth, but also how much of that growth converts into profit.

Our takeaway:

PB Fintech started with a simple idea: make it easier for customers to compare and buy financial products.

Today, it is becoming much broader.

Insurance distribution is growing rapidly. Health insurance is gaining share. Renewal income is becoming meaningful. Paisabazaar adds credit, while PB Partners gives the company a large offline distribution network.

Now PB Health adds healthcare delivery to the mix.

The core business is already showing strong operating leverage, ₹1,888 Cr of quarterly revenue, 40% growth, and a 9% PAT margin in Q1 FY27.

The next question is whether PB Fintech can successfully scale its newer businesses without losing the profitability it has worked hard to build.

The insurance marketplace built PB Fintech. The larger ecosystem could determine how big it eventually becomes.